PolyCore Therapeutics LLC is a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders.

PolyCore Therapeutics LLC is a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders. PolyCore is current conducting preclinical studies for its lead compound, PCT-3012, a novel G protein-biased agonist of the D3 receptor, for treatment of Parkinson?s motor symptoms and dyskinesia in patients with early- to mid-stage Parkinson’s Disease.

Industry: Health
Status: Active
County: Philadelphia

Contact Information

http://www.polycoretherapeutics.com

jim.harris648@gmail.com

Jim Harris

Co-Founder & CEO

Sandhya Kortagere

Co-Founder & CSO

Mike Saporito

COO